Trial intelligence / Profile preview

Low Dose IV Tranexamic Acid in Total Knee Arthroplasty

NCT02327117Completed

Start
Jan 2013
Primary completion
Jan 2015
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of tranexamic acid (2 arms). Primary endpoint: Hemoglobin Level. Started Jan 2013; status: completed.

02

Drugs

tranexamic acid

Beyond the preview

Go deeper on NCT02327117.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02327117.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call